Interestingly, the expression of BCL2A1 was strictly limited to the ABC-DLBCL subtype in our cell line panel (Fig. 5g), which is more likely to harbor mutations driving BTK-dependent chronic active BCR signaling. Here, BCR is linked to aneurysmal bone cyst.